Eli Lilly Joins Northlake’s Widely Held Stock Portfolio
We recently added Ely Lilly (LLY) to client accounts that employ Northlake’s individual stock strategy. LLY fits the profile we have been looking for to add to the widely held stock portfolio: blue chip financial strength, above-average long-term growth with a reasonable valuation, and diversification from consumer discretionary and consumer technology. We believe LLY can […]
